Bristol-Myers Squibb Co (BMS) is a speciality biopharmaceutical company that is engaged in the discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, US.
COBENFY for the Treatment of Schizophrenia, US
Schizophrenia is a chronic and debilitating mental disorder that impacts the way an individual thinks, feels, and acts.
